Propiconazole Induces Alterations in the Hepatic Metabolome of Mice: Relevance to Propiconazole-Induced Hepatocarcinogenesis (Q42753914)

6 November 2017

title

Propiconazole induces alterations in the hepatic metabolome of mice: relevance to propiconazole-induced hepatocarcinogenesis (English)

1 reference

6 November 2017

Propiconazole Induces Alterations in the Hepatic Metabolome of Mice: Relevance to Propiconazole-Induced Hepatocarcinogenesis (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

23 November 2024

Stephen Nesnow

1 reference

6 November 2017

Tanya Moore

series ordinal

1 reference

6 November 2017

William T. Padgett

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21278054

23 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21278054

23 November 2024

publication date

27 January 2011

1 reference

6 November 2017

published in

Toxicological Sciences

1 reference

6 November 2017

volume

120

1 reference

6 November 2017

1 reference

6 November 2017

page(s)

297-309

1 reference

Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

High turnover rate of transfer RNA in tumor tissue

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Discovery of metabolomics biomarkers for early detection of nephrotoxicity

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Protein carbonyl formation in response to propiconazole-induced oxidative stress

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Acyl-coenzyme A:cholesterol acyltransferases

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Cytotoxic effects of propiconazole and its metabolites in mouse and human hepatoma cells and primary mouse hepatocytes

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Comparative metabolism and toxicity of dichlorobenzenes in Sprague-Dawley, Fischer-344 and human liver slices

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Cancer chemoprevention locks onto a new polyamine metabolic target

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Causes and consequences of increased glucose metabolism of cancers

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Regulation of the mevalonate pathway

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Discovery of metabolic signatures for predicting whole organism toxicology

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Identification of biliary metabolites of m-dichlorobenzene in rats

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

UDP-Glucuronosyltransferases

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

The role of oxidative stress in carcinogenesis

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Proteome analysis of hepatocellular carcinoma

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Antizyme, a protein induced by polyamines, accelerates the degradation of ornithine decarboxylase in Chinese-hamster ovary-cell extracts

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Adventures in hepatocarcinogenesis

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

A potential microRNA signature for tumorigenic conazoles in mouse liver

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Analysis of the mutations induced by conazole fungicides in vivo.

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Statistical significance for genomewide studies

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Serum pseudouridine as a biochemical marker in small cell lung cancer

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Polyamine metabolism and cancer.

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles.

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Biochemical approaches to selective antifungal activity. Focus on azole antifungals

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Understanding the Warburg effect: the metabolic requirements of cell proliferation

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Carnitine biosynthesis in mammals

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

PXR and CAR in energy metabolism

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.

23 November 2024

1 reference

https://api.crossref.org/works/10.1093/TOXSCI/KFR012

23 November 2024

Identifiers

DOI

1 reference

6 November 2017

1 reference